Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Allos Therapeutics to test lymphoma drug
“Therapies currently used to treat cutaneous T-cell lymphoma fail to produce durable remissions in the majority of patients with advanced disease,” said Pablo Cagnoni, chief medical officer of
“Therapies currently used to treat cutaneous T-cell lymphoma fail to produce durable remissions in the majority of patients with advanced disease,” said Pablo Cagnoni, chief medical officer of
Administered via deep muscular injection, Bicillin C-R is indicated for the treatment of pediatric and adult infections caused by penicillin-G-susceptible bacteria, including moderately severe to severe upper-respiratory tract
The trial combines nimotuzumab with radiation for the treatment of diffuse intrinsic pontine glioma (DIPG), an inoperable form of brain cancer. The trial is being conducted by an
Pacira says DepoDur is the only extended-release opioid that is approved by the FDA for epidural use. A single injection of DepoDur into the lumbar epidural space may
The agency submitted its opinion to the European Commission (EC) for orphan designation determination. This will become effective upon adoption of the recommendation by the EC, which is
The label will contain a boxed warning, which increases the prominence of an already existing warning for all medicines in the TZD class on the risk of congestive
CombinatoRx says it selected CRx-401 for clinical evaluation based on preclinical data demonstrating decreased fasting glucose and insulin resistance without weight gain. According to the company, CRx-401 offers
GSK-923295 is a small-molecule inhibitor of centromere-associated protein E (CENP-E). As reported at the 2007 annual meeting of the American association for cancer research (AACR), GSK-923295 demonstrated a
The manufacturing facility is located near Baltimore, Maryland. Once fully built out to Cel-Sci’s specifications, the facility will produce Multikine for both its Phase III clinical trials for
GSK says severe, dehydrating gastroenteritis occurs primarily among children aged three to 35 months. Of children hospitalized with rotavirus, approximately 17% are younger than six months old. If